Boxed Warning on risk of severe hypocalcaemia with denosumab

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 1992卷 / 1期

关键词：

D O I：

10.1007/s40278-024-52736-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Denosumab information updated with risk of severe hypocalcaemia
Reactions Weekly, 2024, 1994 (1) : 1 - 1
[2] Denosumab/PrednisoloneOsteoporosis and severe hypocalcaemia
Reactions Weekly, 2024, 2002 (1) : 161 - 161
[3] Severe hypocalcaemia post-denosumab
Martin-Baez, Isabel M.
Blanco-Garcia, Raquel
Alonso-Suarez, Mario
Cossio-Aranibar, Cynthia
Beato-Coo, Laura V.
Fernandez-Fleming, Francisco
NEFROLOGIA, 2013, 33 (04): : 614 - 615
[4] Severe hypocalcaemia following denosumab and iron infusion
Cohen, Adrienne
Chacko, Bobby
NEPHROLOGY, 2022, 27 (09) : 781 - 782
[5] Hypocalcaemia risk with concomitant denosumab and cinacalcet
Reactions Weekly, 2021, 1886 (1) : 2 - 2
[6] Safety information regarding the risk of severe and sometimes fatal hypocalcaemia with denosumab [XGEVA]
Reactions Weekly, 2012, 1416 (1) : 5 - 5
[7] Severe symptomatic hypocalcaemia following a single dose of denosumab
McLachlan, Jennifer M.
Marx, Gavin M.
Bridgman, Margaret
MEDICAL JOURNAL OF AUSTRALIA, 2013, 199 (04) : 242 - 243
[8] Evaluation of the risk of Denosumab-Associated Hypocalcaemia
Krahenbule, A.
Morel, A.
Aubert, L.
Azzouz, B.
Trenque, T.
DRUG SAFETY, 2017, 40 (10) : 1025 - 1025
[9] SEVERE HYPOCALCAEMIA AND HYPOPHOSPHATAEMIA FOLLOWING INTRAVENOUS IRON AND DENOSUMAB
Smyth, B.
Ong, S.
NEPHROLOGY, 2015, 20 : 61 - 61
[10] Propylthiouracil: boxed warning on severe liver injury
Reactions Weekly, 2010, 1299 (1) : 2 - 2

← 1 2 3 4 5 →